HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Tapang Selected Research

Colorectal Neoplasms (Colorectal Cancer)

10/2012Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul Tapang Research Topics

Disease

13Neoplasms (Cancer)
12/2012 - 01/2002
3Fibrosarcoma
07/2011 - 04/2006
2Carcinoma (Carcinomatosis)
07/2011 - 11/2003
2Edema (Dropsy)
04/2007 - 04/2006
1Multiple Myeloma
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2012
1Lymphoma (Lymphomas)
12/2012
1Hematologic Neoplasms (Hematological Malignancy)
12/2012
1Leukemia
12/2012
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2012
1Polyploidy
12/2012
1Colorectal Neoplasms (Colorectal Cancer)
10/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2012
1Hypertension (High Blood Pressure)
06/2009
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2007
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2006
1Glioma (Gliomas)
04/2006
1Corneal Neovascularization
04/2006
1Carcinogenesis
04/2005
1Sarcoma (Soft Tissue Sarcoma)
11/2003
1Neuroblastoma
11/2003

Drug/Important Bio-Agent (IBA)

5linifanibIBA
06/2012 - 04/2006
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2011 - 04/2007
2Proteins (Proteins, Gene)FDA Link
01/2016 - 07/2011
2Urea (Carbamide)FDA LinkGeneric
05/2012 - 06/2009
2Phosphotransferases (Kinase)IBA
04/2007 - 04/2006
1venetoclaxIBA
01/2016
1Bortezomib (Velcade)FDA Link
01/2016
1navitoclaxIBA
01/2016
1ilorasertibIBA
12/2012
1src-Family KinasesIBA
12/2012
1Histones (Histone)IBA
12/2012
1Imatinib Mesylate (Gleevec)FDA Link
12/2012
1Irinotecan (Camptosar)FDA LinkGeneric
10/2012
1Glucose (Dextrose)FDA LinkGeneric
10/2012
1ThymidineIBA
10/2012
1Biomarkers (Surrogate Marker)IBA
06/2012
1diphenyl (biphenyl)IBA
05/2012
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2011
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2009
1Angiotensin Receptor AntagonistsIBA
06/2009
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
06/2009
1EnalaprilFDA LinkGeneric
06/2009
1Antihypertensive Agents (Antihypertensives)IBA
06/2009
1TransferasesIBA
04/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2007
1Estradiol (Delestrogen)FDA LinkGeneric
04/2007
1Blood Proteins (Serum Proteins)IBA
04/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2006
1Small Interfering RNA (siRNA)IBA
04/2005
1Polo-Like Kinase 1IBA
04/2005
1AgarIBA
04/2005
1AminopeptidasesIBA
11/2003
1Antineoplastic Agents (Antineoplastics)IBA
11/2003
1O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
11/2003
1A357300IBA
11/2003
1Methionine (L-Methionine)FDA Link
11/2003
1EnzymesIBA
11/2003
1AmidesIBA
10/2003
1N- (1- (2,2- dimethyl- 1,3- dioxol- 4- yl)- 2- ((4,4- (trifluoromethoxyphenoxy)phenyl)sulfonyl)ethyl)- N- hydroxyformamideIBA
01/2002
1Matrix Metalloproteinase InhibitorsIBA
01/2002

Therapy/Procedure

2Therapeutics
10/2012 - 11/2003
1Intraperitoneal Injections
10/2012
1Aftercare (After-Treatment)
07/2011